Loading stock data…
Viatris Inc (VTRS)
$16.33+0.26 (+1.62%)
Market ClosedLast close Jun 26
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Viatris Inc. in the Healthcare sector is trading at $16.33 with a market capitalization of $18.9B. Wall Street consensus targets $17.81 (8 analysts), implying a +9.1% move over the next 12 months. The stock is currently near its 52-week high of $17.53, remaining 26.4% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +9.1% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.52B↓ | $3.70B↓ | $3.76B↑ | $3.58B↑ | $3.25B |
| Gross Profit | $1.16B↑ | $1.15B↓ | $1.37B↑ | $1.33B↑ | $1.16B |
| Operating Income | -$20.20M↑ | -$157.50M↓ | $234.50M↑ | $185.40M↑ | -$8.90M |
| Net Income | $176.40M↑ | -$340.10M↓ | -$128.20M↓ | -$4.60M↑ | -$3.04B |
Peer Comparison
JNJUNHPFE
Fundamentals
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$18.89B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Strong income play. Yield provides a meaningful total return floor.
2.20%
ROE
Average efficiency. Growth may require heavy reinvestment.
-2.02%
Volume
Today's trading volume
12.85M
Recent News
VTRS vs. DHR: Which Stock Is the Better Value Option?
VTRS vs. DHR: Which Stock Is the Better Value Option?
Are Investors Undervaluing Viatris (VTRS) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
How Is Viatris’ Stock Performance Compared to Other Healthcare Stocks?
Viatris has outperformed its industry peers over the past year, and Wall Street appears optimistic about the stock.
FDA Seeks Updated Labeling for Testosterone Therapies
The US Food and Drug Administration said Thursday it is requesting updates to prescribing informatio
1 Cash-Producing Stock with Exciting Potential and 2 Facing Headwinds
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.